Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Flexion tanks as FDA clamps a hold on its lead osteoarthritis drug
Fierce Biotech
Thursday, September 18, 2014 - 9:25am
tags:
FDA, Flexion, osteoarthritis of the knee, FX0006
Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Fierce Biotech
Thursday, September 18, 2014 - 9:24am
tags:
Merck, diabetes, Januvia, omarigliptin, MK-3102
Are obesity drugs nearing a breakout? Novo, Takeda think so
Fierce Pharma
Thursday, September 18, 2014 - 9:18am
tags:
Novo Nordisk, Takeda, obesity, Saxenda
UCB-Amgen Reveals Positive Data on Romosozumab for PMO
Yahoo/Zacks.com
Thursday, September 18, 2014 - 9:17am
tags:
Amgen, UCB Pharmaceuticals, romosozumab, low bone mineral density
Faster-acting erectile dysfunction drug gets FDA approval
Yahoo/Reuters
Thursday, September 18, 2014 - 9:13am
tags:
FDA, erectile dysfunction, Vivus, Auxilium, Stendra
Auxilium Mulls Endo Bid; Is $2.2 Billion Enough?
Investors.com
Thursday, September 18, 2014 - 9:07am
tags:
Auxilium, Endo Health Solutions, M&A
Ranbaxy Faces Medicaid Pricing Probe by the Justice Department
WSJ Pharmalot
Thursday, September 18, 2014 - 9:01am
tags:
Ranbaxy, Medicaid, DOJ
GSK melanoma pill backed by UK cost watchdog with price cut
Yahoo/Reuters
Thursday, September 18, 2014 - 8:59am
tags:
GSK, UK, melanoma, Tafinlar
FDA panel recommends scaling back testosterone use in men, citing little evidence of benefit
Yahoo/AP
Thursday, September 18, 2014 - 8:57am
tags:
FDA, advisory panels, testosterone, AbbVie, Eli Lilly
Merck KGaA seeks partner for immuno-oncology drug by year-end
Yahoo/Reuters
Thursday, September 18, 2014 - 8:55am
tags:
Merck KGaA, immuno-oncology, anti-PD-L1
Sanofi, MannKind say cutting insulin costs will make Afrezza more competitive
Fierce Pharma Marketing
Wednesday, September 17, 2014 - 5:47pm
tags:
Sanofi, MannKind, insulin, diabetes, Afrezza
India Must Fix Its Drug Quality Problem
Forbes
Wednesday, September 17, 2014 - 5:38pm
tags:
India, drug manufacturing
Resmed-FairView Sleep Apnea Data Sharing Drags Shares
Yahoo/Zacks.com
Wednesday, September 17, 2014 - 5:36pm
tags:
sleep apnea, ResMed, Fair View Health Services
First-to-market launch? Bonus--but double bonus if you're Big Pharma
Fierce Pharma Marketing
Wednesday, September 17, 2014 - 5:12pm
tags:
drug launches, Big Pharma
Armed with 900 reps, Takeda aims for the Contrave marketing hat-trick
Fierce Pharma Marketing
Wednesday, September 17, 2014 - 5:10pm
tags:
Takeda, drug reps, Contrave, obesity, Orexigen
Five Prime Therapeutics' Novel Target Licensed by Glaxo
Yahoo/Zacks.com
Wednesday, September 17, 2014 - 5:08pm
tags:
Five Prime, GSK
'Fastest way to biosimilar approval? As the CRO flies,' says industry group
Bio-Pharma Reporter
Wednesday, September 17, 2014 - 4:55pm
tags:
biosimilars, CROs, drug approvals
Sanofi Still Ahead Of Novo Nordisk In Insulin Drug Race
Bidness Etc.
Wednesday, September 17, 2014 - 4:53pm
tags:
Sanofi, Novo Nordisk, diabetes, insulin, Lantus, Tresiba, Toujeo
What Will the NY AG Anti-Trust Lawsuit Mean for Actavis?
WSJ Pharmalot
Wednesday, September 17, 2014 - 4:37pm
tags:
antitrust, Actavis, Namenda XR, Namenda, Alzheimer's disease
Merck licenses experimental psoriasis drug to India's Sun Pharma
Yahoo/Reuters
Wednesday, September 17, 2014 - 4:35pm
tags:
Merck, Sun Pharma, psoriasis, tildrakizumab, India

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.